Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Nov 11;390(10108):2183-2193.
doi: 10.1016/S0140-6736(17)31469-1. Epub 2017 May 31.

Glaucoma

Affiliations
Review

Glaucoma

Jost B Jonas et al. Lancet. .

Abstract

Glaucoma is a heterogeneous group of diseases characterised by cupping of the optic nerve head and visual-field damage. It is the most frequent cause of irreversible blindness worldwide. Progression usually stops if the intraocular pressure is lowered by 30-50% from baseline. Its worldwide age-standardised prevalence in the population aged 40 years or older is about 3·5%. Chronic forms of glaucoma are painless and symptomatic visual-field defects occur late. Early detection by ophthalmological examination is mandatory. Risk factors for primary open-angle glaucoma-the most common form of glaucoma-include older age, elevated intraocular pressure, sub-Saharan African ethnic origin, positive family history, and high myopia. Older age, hyperopia, and east Asian ethnic origin are the main risk factors for primary angle-closure glaucoma. Glaucoma is diagnosed using ophthalmoscopy, tonometry, and perimetry. Treatment to lower intraocular pressure is based on topical drugs, laser therapy, and surgical intervention if other therapeutic modalities fail to prevent progression.

PubMed Disclaimer

Comment in

  • Glaucoma.
    Ben Salem C, Fathallah N, Zayani H. Ben Salem C, et al. Lancet. 2018 Feb 24;391(10122):739-740. doi: 10.1016/S0140-6736(18)30306-4. Lancet. 2018. PMID: 29486942 No abstract available.
  • Glaucoma - Authors' reply.
    Jonas JB, Aung T, Bourne RR, Bron AM, Ritch R, Panda-Jonas S. Jonas JB, et al. Lancet. 2018 Feb 24;391(10122):740. doi: 10.1016/S0140-6736(18)30305-2. Lancet. 2018. PMID: 29486943 No abstract available.

MeSH terms